You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase III clinical trial

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteoarthritis, Knee Trial in Seoul (SKCPT, Celebrex)

Completed
  • Osteoarthritis, Knee
  • Seoul, Korea, Republic of
    Asan Medical Center
Jul 3, 2023

Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)

Not yet recruiting
  • Essential Hypertension
  • NW Roselle
  • Captopril 25Mg Tab
  • (no location specified)
Nov 15, 2023

HER2-positive Breast Cancer Trial in Nanjing (HS022, Trastuzumab, Vinorelbine Bitartrate)

Completed
  • HER2-positive Breast Cancer
  • Nanjing, Jiangsu, China
    Jiangsu Province People's Hospital (First Affiliated Hospital of
Oct 25, 2023

NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
  • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
  • Tianjing, Tianjin, China
    Tianjin cancer hospital
Nov 3, 2023

COVID-19 SARS-CoV-2 Infection Trial (CoronaVac, SCTV01E)

Not yet recruiting
  • COVID-19 SARS-CoV-2 Infection
  • CoronaVac
  • SCTV01E
  • (no location specified)
Jan 4, 2023

Glabellar Lines Trial (Botulinum Toxin Type A Injection [HG102], Botulinum Toxin Type A Injection [Botox])

Not yet recruiting
  • Glabellar Lines
  • Botulinum Toxin Type A Injection [HG102]
  • Botulinum Toxin Type A Injection [Botox]
  • (no location specified)
Apr 5, 2023

Psoriasis Trial in Shanghai (LZM012, Secukinumab)

Recruiting
  • Psoriasis
  • LZM012
  • Secukinumab
  • Shanghai, Shanghai, China
    Huashan Hospital
Oct 29, 2023

Seasonal Influenza Trial in China (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent

Not yet recruiting
  • Seasonal Influenza
  • Quadrivalent influenza vaccine(0.25ml)
  • +3 more
  • Lu'an, Anhui, China
  • +4 more
Sep 15, 2023

Functional Dyspepsia Trial in Iksan (DA-5212, DA-5212-R)

Not yet recruiting
  • Functional Dyspepsia
  • Iksan, Muwangro 895, Korea, Republic of
    Wonkwang University Hospital
Apr 24, 2023

Varicella Trial in Xuzhou (Investigational live attenuated varicella vaccine, Placebo of live attenuated varicella vaccine)

Recruiting
  • Varicella
  • Investigational live attenuated varicella vaccine
  • Placebo of live attenuated varicella vaccine
  • Xuzhou, Jiangsu, China
    Pei County Center for Disease Control and Prevention
Jan 18, 2023

HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)

Not yet recruiting
  • HR+/HER2-breast Cancer
  • Standard endocrine therapy plus Apatinib
  • (no location specified)
Jun 2, 2023

Stress Ulcer Bleeding Trial in Shanghai, Urumchi (Esomeprazole 40mg, Ilaprazole Sodium, Placebo 1)

Completed
  • Stress Ulcer Bleeding
  • Esomeprazole 40mg
  • +3 more
  • Shanghai, Shanghai, China
  • +1 more
Apr 22, 2023

Epidermolysis Bullosa Trial in Minneapolis (allo-APZ2-OTS, Placebo)

Not yet recruiting
  • Epidermolysis Bullosa
  • Minneapolis, Minnesota
    Masonic Cancer Center and Medical Center Minneapolis
Apr 20, 2023

Glabellar Frown Lines Trial (PROTOXIN)

Not yet recruiting
  • Glabellar Frown Lines
  • PROTOXIN
  • (no location specified)
Nov 8, 2023

Allergic Rhinitis Trial (CM310, Placebo)

Not yet recruiting
  • Allergic Rhinitis
  • CM310
  • Placebo
  • (no location specified)
Jun 15, 2023

Moderate to Severe Active Rheumatoid Arthritis Trial in Beijing (HS628+MTX, Actemra +MTX)

Completed
  • Moderate to Severe Active Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 14, 2023

Norovirus Infections, Norwalk Gastroenteritis Trial (Human Norovirus Bivalent (G?.1/G?.4)Vaccine,Recombinant (Hansenula

Not yet recruiting
  • Norovirus Infections
  • Norwalk Gastroenteritis
  • Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)
  • placebo
  • (no location specified)
Jun 14, 2023

Gastric or Esophagogastric Junction Adenocarcinoma Trial (nimotuzumab plus paclitaxel, plus paclitaxel)

Not yet recruiting
  • Gastric or Esophagogastric Junction Adenocarcinoma
  • nimotuzumab plus paclitaxel
  • placebo plus paclitaxel
  • (no location specified)
Aug 3, 2023

Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

Not yet recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • (no location specified)
Jun 11, 2023

COVID-19 Trial in Xi'an (Meplazumab for injection, Normal saline)

Recruiting
  • COVID-19
  • Meplazumab for injection
  • Normal saline
  • Xi'an, China
    First Affiliated Hospital of the Air Force Medical University
Apr 13, 2023

Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)

Enrolling by invitation
  • Esophageal Squamous Cell Carcinoma
  • Nanjing, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023

Locally Advanced Cervical Cancer, Gemcitabine, Chemo-radiotherapy Trial in México (Gemcitabine, Cisplatin)

Recruiting
  • Locally Advanced Cervical Cancer
  • +2 more
  • México, Ciudad De México, Mexico
    National Cancer Institute of Mexico
Nov 27, 2023

Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023

COVID-19, Coronavirus Infections Trial in Seha (LIBP-Rec-Vaccine, BIBP-Rec-Vaccine, )

Recruiting
  • COVID-19
  • Coronavirus Infections
  • LIBP-Rec-Vaccine
  • +2 more
  • Seha, Abu Dhab, United Arab Emirates
    Sheikh Khalifa Medical City
Nov 7, 2022

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023